Syndax – Expanding outside of the USA
Syndax are a commercial stage oncology innovator seeking to develop first-in-class therapies in areas of significant unmet need such as acute leukaemia and chronic graft-versus-host disease. Following FDA approval on two indications they saw the opportunity to build outside the US to support clinical trial activity.....


